TGFB1 and peritoneum cancer: We make the hypothesis that the use of tamoxifen, phytoestrogens or other TGF-β1/HIF/TKR blockade may facilitate the effects of intraperitoneal chemotherapy, particularly in peritoneal cancers with high levels of TGF-β1 expression and mesenchymal phenotypes.